Biologic TNF inhibiting agents for treatment of inflammatory rheumatic diseases: dosing patterns and related costs in Switzerland from a payers perspective
Zeidler J, Mittendorf T, Müller R, von Kempis J. Biologic TNF inhibiting agents for treatment of inflammatory rheumatic diseases: dosing patterns and related costs in Switzerland from a payers perspective. Health Econ Rev 2012; 2:20.
28.09.2012
Biologic TNF inhibiting agents for treatment of inflammatory rheumatic diseases: dosing patterns and related costs in Switzerland from a payers perspective
28.09.2012
Health Econ Rev 2012; 2:20
Zeidler Jan, Mittendorf Thomas, Müller Rüdiger, von Kempis Johannes
Weiter
